Antibodies, Assay Kits, Biology Cells, Brd4 Antibody, Clia Kits, Ctip Antibody, Culture Cells, DNA Testing, Enzymes, Equipments, Exosomes, Gels, Irak3 Antibody, Nmnat1 Antibody, Nse Antibody, Otx2 Antibody, Panel, PCR, Ria Kits, RNA, Setd2 Antibody, Stat5 Antibody, Trpa1 Antibody, Vector & Virus, Vitronectin Antibody

Evaluation of the diagnostic test for rapid detection of covid-19 antigen (Panbio Covid rapid test) in primary care

Goal: COVID-19 an infection requires early analysis, with PCR being the gold customary take a look at. The protocols advocate using fast antigenic assessments that require analysis in precise scientific apply. The target was to judge the diagnostic take a look at for fast antigen detection, Panbio Covid fast take a look at, in contrast with PCR, in sufferers with signs of 5 or much less days of evolution and with a high-suspicion of an infection by COVID-19 in a well being middle.
Supplies and strategies: 103 sufferers over 14 years of age who attended an city well being middle situated within the Usera District of Madrid, with high-suspicion of COVID-19 an infection, within the first 5 days of evolution from the onset of signs through the month of November 2020.
Interventions: diagnostic assessments for COVID-19 are carried out: antigen and PCR.
Outcomes: The prevalence of the illness was 24.3% based on the PCR take a look at and 17.5% based on the fast antigenic take a look at. The sensitivity was 72% (95% CI: 54.3-89.6%). The specificity was 100%. The optimistic and adverse predictive values have been 100% and 91.8% respectively. Within the bivariate evaluation, there was no relationship between signs and the presence of illness, aside from myalgias (p=0.030). The multivariate evaluation discovered a relationship between cough, dyspnea, fever, myalgia, anosmia/ageusia, and ocular signs and the presence of illness.
Conclusions: The sensitivity and specificity for the Panbio fast antigen take a look at are just like different research carried out in major care. In high-prevalence of illness and with extremely suspected signs, optimistic take a look at outcomes may be thought-about definitive, however adverse outcomes would require affirmation. Myalgia, fever, dyspnea, anosmia/ageusia, and ocular signs could also be extra associated to the presence of COVID-19.
Objetivo: La infección por covid-19 requiere un diagnóstico temprano, siendo la PCR la prueba gold estándar. Los protocolos propugnan el uso de pruebas antigénicas rápidas que precisan de evaluación en la práctica clínica actual. El objetivo fue evaluar la prueba diagnóstica de detección rápida de antígeno, Panbio Covid fast take a look at, comparada con la PCR, en los pacientes con clínica de 5 o menos días de evolución y con alta sospecha de infección por covid-19 en un centro de salud.
Materiales y métodos: Un complete de 103 pacientes mayores de 14 años que acudieron a un centro de salud urbano ubicado en el Distrito de Usera de Madrid, con alta sospecha de infección por covid-19, en los primeros 5 días de evolución desde el inicio de los síntomas durante el mes de noviembre de 2020. Como intervenciones se realizan las pruebas diagnósticas de covid-19: antígeno y PCR.
Resultados: La prevalencia de la enfermedad fue del 24,3% según la prueba PCR y del 17,5% según el take a look at antigénico rápido. La sensibilidad fue del 72% (IC al 95%: 54,3-89,6%). La especificidad fue del 100%.
Los valores predictivos positivo y negativo fueron del 100% y del 91,8%, respectivamente. En el análisis bivariante, no hubo relación entre los síntomas y la presencia de enfermedad, excepto para las mialgias (p = 0,030). En el análisis multivariado se encontró relación entre la tos, la disnea, la fiebre, las mialgias, la anosmia/ageusia y los síntomas oculares y la presencia de enfermedad.
Conclusiones: La sensibilidad y la especificidad para el take a look at de antígeno rápido Panbio son similares a otros estudios realizados en atención primaria. En prevalencia alta de enfermedad y con síntomas de alta sospecha, los resultados positivos del take a look at se pueden considerar definitivos, pero los resultados negativos requerirán confirmación. Las mialgias, la fiebre, la disnea, la anosmia/ageusia y los síntomas oculares se pueden relacionar más con la presencia de covid-19.
Key phrases: Atención Primaria de Salud; COVID-19; Diagnostic assessments; Prevalence; Prevalencia; Major well being care; Pruebas diagnósticas; Sensibilidad y especificidad; Sensitivity and specificity.
milansystem
milansystem

Reliability and validity of PSQI amongst frontline well being care staff of COVID-19 utilizing classical take a look at idea and merchandise response idea

Examine targets: The applicability of sleep-related scale in frontline medical employees of COVID-19 epidemic has not been absolutely proved, so the sleep survey outcomes lack credibility and accuracy, which brings difficulties to the steerage and remedy of frontline medical employees with sleep problems, and isn’t conducive to the prevention and management of COVID-19 epidemic. This research sought to research the reliability and validity of the Pittsburgh Sleep High quality Index (PSQI) among the many frontline medical employees preventing in opposition to COVID-19 epidemic.
Strategies: A community questionnaire survey was used to research PSQI amongst frontline medical employees who fought in opposition to COVID-19 in Wuhan from March 19 to April 15, 2020. Mixed with classical take a look at idea (CTT) and merchandise response idea (IRT), the content material validity, inner consistency, assemble validity and others of PSQI have been evaluated.
Outcomes: In accordance with CTT, content material validity, criterion validity, and assemble validity of PSQI was good. However the inner consistency was higher after the deletion of “daytime dysfunction” subscale. As for IRT, problem, differential merchandise operate and wright map carried out properly.
Conclusions: The unique PSQI confirmed acceptable applicability in frontline anti-epidemic medical employees, and its traits reasonably improved after “daytime dysfunction” subscale was eliminated.
Key phrases: COVID-19; Pittsburgh Sleep High quality Index; frontline well being care staff; validity.

Aspergillus take a look at profiles and mortality in critically-ill COVID-19 sufferers

Background The literature relating to COVID-19 related pulmonary aspergillosis (CAPA) has proven conflicting observations, together with survival of CAPA sufferers not receiving antifungal remedy and discrepancy between CAPA analysis and post-mortem findings. To realize perception into the pathophysiology of CAPA we carried out a case-control research, through which we in contrast Aspergillus take a look at profiles in CAPA sufferers and controls in relation to ICU-mortality.
Strategies A multinational case-control research, through which Aspergillus take a look at outcomes, use of antifungal remedy and mortality have been collected from critically-ill COVID-19 sufferers. Sufferers have been categorised utilizing the 2020 ECMM/ISHAM consensus case definitions.
 Outcomes 219 critically-ill COVID-19 circumstances have been analyzed, together with one confirmed, 38 possible, 19 potential CAPA circumstances, 21 Aspergillus colonized sufferers, seven sufferers solely optimistic for serum (1, 3)-ß-D-glucan (BDG), and 133 circumstances with no proof of CAPA. Mortality was 53.8% in CAPA sufferers in comparison with 24.1% in sufferers with out CAPA (p=0.001). Constructive serum galactomannan (GM) and BDG have been related to elevated mortality in comparison with serum biomarker adverse CAPA sufferers (87.5% versus 41.7%, p=0.046; 90.0% versus 42.1%, p=0.029, respectively).
For every level improve in GM or ten-point BDG serum focus, the odds of demise elevated (GM, OR 10.208, 95%CI 1.621-64.291, p=0.013; BDG, OR 1.247, 95%CI 1.029-1.511, p=0.024). 
Conclusions CAPA is a fancy illness, in all probability involving a continuum of respiratory colonization, tissue-invasion and angioinvasion. Serum biomarkers are helpful for staging CAPA illness development and, if optimistic, point out angioinvasion and a excessive chance of mortality. There’s want for a biomarker that distinguishes between respiratory tract colonization and tissue invasive CAPA illness.

 

L Wnt-3A cells

S0011001 One Frozen vial
EUR 546

Human Protein Wnt-3a (WNT3A)

1-CSB-RP155494h
  • EUR 456.00
  • EUR 256.80
  • EUR 1570.80
  • EUR 672.00
  • EUR 1047.60
  • EUR 314.40
  • 100ug
  • 10ug
  • 1MG
  • 200ug
  • 500ug
  • 50ug
Description: Recombinant Human Protein Wnt-3a(WNT3A),partial expressed in E.coli

Human Protein Wnt-3a (WNT3A)

1-CSB-EP026136HU
  • EUR 524.40
  • EUR 285.60
  • EUR 1852.80
  • EUR 783.60
  • EUR 1234.80
  • EUR 355.20
  • 100ug
  • 10ug
  • 1MG
  • 200ug
  • 500ug
  • 50ug
Description: Recombinant Human Protein Wnt-3a(WNT3A) expressed in E.coli

Mouse Protein Wnt-3a (Wnt3a)

1-CSB-EP026136MO
  • EUR 524.40
  • EUR 285.60
  • EUR 1852.80
  • EUR 783.60
  • EUR 1234.80
  • EUR 355.20
  • 100ug
  • 10ug
  • 1MG
  • 200ug
  • 500ug
  • 50ug
Description: Recombinant Mouse Protein Wnt-3a(Wnt3a) expressed in E.coli

Protein Wnt-3a Polyclonal Antibody

42596-100ul 100ul
EUR 399.6

Protein Wnt-3a Antibody (HRP)

20-abx108677
  • EUR 493.20
  • EUR 2214.00
  • EUR 718.80
  • EUR 218.40
  • EUR 360.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Protein Wnt-3a Antibody (Biotin)

20-abx105841
  • EUR 493.20
  • EUR 2214.00
  • EUR 718.80
  • EUR 218.40
  • EUR 360.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Protein Wnt-3a Antibody (FITC)

20-abx107257
  • EUR 493.20
  • EUR 2214.00
  • EUR 718.80
  • EUR 218.40
  • EUR 360.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Protein Wnt-3a (WNT3A) Antibody

20-abx136135
  • EUR 594.00
  • EUR 844.80
  • EUR 427.20
  • 100 ul
  • 200 ul
  • 50 ul

Protein Wnt-3a (WNT3A) Antibody

abx117009-100ug 100 ug
EUR 560.4

Protein Wnt-3a (WNT3A) Antibody

20-abx000791
  • EUR 493.20
  • EUR 710.40
  • EUR 218.40
  • EUR 376.80
  • 100 ul
  • 200 ul
  • 20 ul
  • 50 ul

Protein Wnt-3a (WNT3A) Antibody

abx224220-100ug 100 ug
EUR 493.2

Protein Wnt-3a (WNT3A) Antibody

abx218011-100ug 100 ug
EUR 526.8

Wnt-C59

A8685-5 5 mg
EUR 177.6
Description: Wnt-C59 is a selective inhibitor of Wnt signaling with IC50 value of 74 pM [1].

Protein Wnt-3a Polyclonal Conjugated Antibody

C42596 100ul
EUR 476.4

Wnt Family Member 3A (WNT3A) Antibody

20-abx211813
  • EUR 493.20
  • EUR 360.00
  • 100 ul
  • 50 ul

Wnt Family Member 3A (WNT3A) Antibody

20-abx211920
  • EUR 493.20
  • EUR 360.00
  • 100 ul
  • 50 ul

Wnt Antagonist, C59

2063-5
EUR 430.8

Human Protein Wnt-3a(WNT3A) ELISA kit

CSB-EL026136HU-24T 1 plate of 24 wells
EUR 198
Description: Quantitativesandwich ELISA kit for measuring Human Protein Wnt-3a (WNT3A) in samples from serum, plasma. A new trial version of the kit, which allows you to test the kit in your application at a reasonable price.

Human Protein Wnt-3a(WNT3A) ELISA kit

1-CSB-EL026136HU
  • EUR 964.80
  • EUR 6118.80
  • EUR 3244.80
  • 1 plate of 96 wells
  • 10 plates of 96 wells each
  • 5 plates of 96 wells each
Description: Quantitativesandwich ELISA kit for measuring Human Protein Wnt-3a(WNT3A) in samples from serum, plasma. Now available in a cost efficient pack of 5 plates of 96 wells each, conveniently packed along with the other reagents in 5 separate kits.

Mouse Protein Wnt-3a(WNT3A) ELISA kit

CSB-EL026136MO-24T 1 plate of 24 wells
EUR 198
Description: Quantitativesandwich ELISA kit for measuring Mouse Protein Wnt-3a (WNT3A) in samples from serum, plasma, tissue homogenates. A new trial version of the kit, which allows you to test the kit in your application at a reasonable price.

Mouse Protein Wnt-3a(WNT3A) ELISA kit

1-CSB-EL026136MO
  • EUR 964.80
  • EUR 6118.80
  • EUR 3244.80
  • 1 plate of 96 wells
  • 10 plates of 96 wells each
  • 5 plates of 96 wells each
Description: Quantitativesandwich ELISA kit for measuring Mouse Protein Wnt-3a(WNT3A) in samples from serum, plasma, tissue homogenates. Now available in a cost efficient pack of 5 plates of 96 wells each, conveniently packed along with the other reagents in 5 separate kits.

Mouse Wnt3a/ Protein Wnt-3a ELISA Kit

E1594Mo 1 Kit
EUR 685.2

Mouse Wnt3a(Protein Wnt-3a) ELISA Kit

EM0737 96T
EUR 681.12
Description: Method of detection: Double Antibody, Sandwich ELISA;Reacts with: Mus ;Sensitivity: 0.188 ng/ml

ELISA kit for Mouse Protein Wnt-3a

EK4364 96 tests
EUR 663.6
Description: Enzyme-linked immunosorbent assay kit for quantification of Mouse Protein Wnt-3a in samples from serum, plasma, tissue homogenates and other biological fluids.

ELISA kit for Human Protein Wnt-3a

EK4365 96 tests
EUR 663.6
Description: Enzyme-linked immunosorbent assay kit for quantification of Human Protein Wnt-3a in samples from serum, plasma, tissue homogenates and other biological fluids.

Human WNT3A(Protein Wnt-3a) ELISA Kit

EH2146 96T
EUR 681.12
Description: Method of detection: Double Antibody, Sandwich ELISA;Reacts with: Homo sapiens;Sensitivity: 0.938 ng/ml

Human Protein Wnt-3a (WNT3A) ELISA Kit

abx570841-96tests 96 tests
EUR 801.6

Mouse Protein Wnt-3a (WNT3A) ELISA Kit

abx575000-96tests 96 tests
EUR 801.6

Chicken Protein Wnt-3a (WNT3A) ELISA Kit

abx519656-96tests 96 tests
EUR 1093.2

Human Protein Wnt-3a (WNT3A) ELISA Kit

abx251482-96tests 96 tests
EUR 895.2

Mouse Protein Wnt-3a (WNT3A) ELISA Kit

abx255085-96tests 96 tests
EUR 895.2

Human WNT3A/ Protein Wnt-3a ELISA Kit

E2688Hu 1 Kit
EUR 685.2

Mouse Protein Wnt- 3a, Wnt3a ELISA KIT

ELI-06995m 96 Tests
EUR 1038

Chicken Protein Wnt- 3a, WNT3A ELISA KIT

ELI-06996c 96 Tests
EUR 1113.6

Human Protein Wnt- 3a, WNT3A ELISA KIT

ELI-06997h 96 Tests
EUR 988.8

BD Transforming growth factor beta 1human 1 ug

354039 EACH
EUR 279.3

BD Epidermal growth factor human recombinant 100 ug

354052 EACH
EUR 204.06

ELISA kit for Human Protein Wnt-3a (WNT3A)

KTE60023-48T 48T
EUR 424.8
Description: Quantitative sandwich ELISA for measuring Human Protein Wnt-3a (WNT3A) in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids.

ELISA kit for Human Protein Wnt-3a (WNT3A)

KTE60023-5platesof96wells 5 plates of 96 wells
EUR 2702.4
Description: Quantitative sandwich ELISA for measuring Human Protein Wnt-3a (WNT3A) in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids.

ELISA kit for Human Protein Wnt-3a (WNT3A)

KTE60023-96T 96T
EUR 686.4
Description: Quantitative sandwich ELISA for measuring Human Protein Wnt-3a (WNT3A) in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids.

ELISA kit for Mouse Protein Wnt-3a (WNT3A)

KTE70008-48T 48T
EUR 398.4
Description: Quantitative sandwich ELISA for measuring Mouse Protein Wnt-3a (WNT3A) in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids.

ELISA kit for Mouse Protein Wnt-3a (WNT3A)

KTE70008-5platesof96wells 5 plates of 96 wells
EUR 2538
Description: Quantitative sandwich ELISA for measuring Mouse Protein Wnt-3a (WNT3A) in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids.

ELISA kit for Mouse Protein Wnt-3a (WNT3A)

KTE70008-96T 96T
EUR 646.8
Description: Quantitative sandwich ELISA for measuring Mouse Protein Wnt-3a (WNT3A) in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids.

Growth Factor Set IV, StemBoost?

K426-5
EUR 1024.8

5-HT-3A Antibody

34152-100ul 100ul
EUR 302.4

5-HT-3A Antibody

34152-50ul 50ul
EUR 224.4

5- HT- 3A Antibody

ABD3502 100 ug
EUR 525.6

Human Growth Differentiation Factor 5 (GDF-5) Antibody

30011-05111 150 ug
EUR 313.2

Mouse Growth/differentiation factor 5 (Gdf5)

1-CSB-EP009349MO
  • EUR 606.00
  • EUR 318.00
  • EUR 2192.40
  • EUR 919.20
  • EUR 1461.60
  • EUR 402.00
  • 100ug
  • 10ug
  • 1MG
  • 200ug
  • 500ug
  • 50ug
Description: Recombinant Mouse Growth/differentiation factor 5(Gdf5) expressed in E.coli

Growth/differentiation factor 5 Polyclonal Antibody

42178-100ul 100ul
EUR 399.6

Growth Differentiation Factor 5 (GDF5) Antibody

20-abx109840
  • EUR 493.20
  • EUR 2214.00
  • EUR 718.80
  • EUR 218.40
  • EUR 360.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Growth Differentiation Factor 5 (GDF5) Antibody

20-abx103263
  • EUR 510.00
  • EUR 159.60
  • EUR 1412.40
  • EUR 693.60
  • EUR 393.60
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Growth Differentiation Factor 5 (GDF5) Antibody

20-abx103264
  • EUR 526.80
  • EUR 159.60
  • EUR 1479.60
  • EUR 710.40
  • EUR 393.60
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Fibroblast Growth Factor 5 (FGF5) Antibody

20-abx172410
  • EUR 944.40
  • EUR 493.20
  • 1 mg
  • 200 ug

Growth Differentiation Factor 5 (GDF5) Antibody

20-abx172684
  • EUR 861.60
  • EUR 460.80
  • 1 mg
  • 200 ug

Growth Differentiation Factor 5 (GDF5) Antibody

20-abx172685
  • EUR 1095.60
  • EUR 560.40
  • 1 mg
  • 200 ug

Fibroblast Growth Factor 5 (FGF5) Antibody

20-abx123595
  • EUR 493.20
  • EUR 710.40
  • 100 ul
  • 200 ul

Fibroblast Growth Factor 5 (FGF5) Antibody

20-abx128010
  • EUR 477.60
  • EUR 159.60
  • EUR 1328.40
  • EUR 644.40
  • EUR 376.80
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Growth Differentiation Factor 5 (GDF5) Antibody

20-abx128606
  • EUR 510.00
  • EUR 159.60
  • EUR 1412.40
  • EUR 693.60
  • EUR 393.60
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Growth Differentiation Factor 5 (GDF5) Antibody

20-abx006710
  • EUR 493.20
  • EUR 710.40
  • EUR 218.40
  • EUR 376.80
  • 100 ul
  • 200 ul
  • 20 ul
  • 50 ul

Fibroblast Growth Factor 5 (FGF5) Antibody

20-abx009268
  • EUR 360.00
  • EUR 526.80
  • EUR 226.80
  • 100 ul
  • 200 ul
  • 30 ul

Growth Differentiation Factor 5 (GDF5) Antibody

abx026572-400ul 400 ul
EUR 627.6

Growth Differentiation Factor 5 (GDF5) Antibody

abx026572-80l 80 µl
EUR 343.2

Growth Differentiation Factor 5 (GDF5) Antibody

abx031516-400ul 400 ul
EUR 627.6

Growth Differentiation Factor 5 (GDF5) Antibody

abx031516-80l 80 µl
EUR 343.2

Fibroblast Growth Factor 5 (FGF5) Antibody

abx233094-100ug 100 ug
EUR 610.8

Growth Differentiation Factor 5 (GDF5) Antibody

abx432738-200ul 200 ul
EUR 343.2

Growth Differentiation Factor 5 (GDF5) Antibody

20-abx320075
  • EUR 360.00
  • EUR 292.80
  • 100 ul
  • 50 ul

Fibroblast Growth Factor 5 (FGF5) Antibody

20-abx323550
  • EUR 376.80
  • EUR 292.80
  • 100 ug
  • 50 ug

Growth Differentiation Factor 5 (GDF5) Antibody

20-abx327566
  • EUR 376.80
  • EUR 292.80
  • 100 ug
  • 50 ug

Growth Differentiation Factor 5 (GDF5) Antibody

20-abx176717
  • EUR 1479.60
  • EUR 710.40
  • 1 mg
  • 200 ug

Growth Differentiation Factor 5 (GDF5) Antibody

20-abx176718
  • EUR 1562.40
  • EUR 744.00
  • 1 mg
  • 200 ug

Recombinant Fibroblast Growth Factor 5 (FGF5)

4-RPA357Hu01
  • EUR 636.10
  • EUR 294.00
  • EUR 2055.36
  • EUR 765.12
  • EUR 1410.24
  • EUR 501.60
  • EUR 4958.40
  • 100 ug
  • 10ug
  • 1 mg
  • 200 ug
  • 500 ug
  • 50ug
  • 5 mg
Description: Recombinant Human Fibroblast Growth Factor 5 expressed in: E.coli

Recombinant Growth Differentiation Factor 5 (GDF5)

4-RPC110Hu01
  • EUR 571.58
  • EUR 276.00
  • EUR 1813.44
  • EUR 684.48
  • EUR 1248.96
  • EUR 458.40
  • EUR 4353.60
  • 100 ug
  • 10ug
  • 1 mg
  • 200 ug
  • 500 ug
  • 50ug
  • 5 mg
Description: Recombinant Human Growth Differentiation Factor 5 expressed in: E.coli

Recombinant Growth Differentiation Factor 5 (GDF5)

4-RPC110Hu02
  • EUR 582.34
  • EUR 279.60
  • EUR 1853.76
  • EUR 697.92
  • EUR 1275.84
  • EUR 465.60
  • EUR 4454.40
  • 100 ug
  • 10ug
  • 1 mg
  • 200 ug
  • 500 ug
  • 50ug
  • 5 mg
Description: Recombinant Human Growth Differentiation Factor 5 expressed in: E.coli

Recombinant Growth Differentiation Factor 5 (GDF5)

4-RPC110Mu01
  • EUR 496.32
  • EUR 256.80
  • EUR 1531.20
  • EUR 590.40
  • EUR 1060.80
  • EUR 408.00
  • EUR 3648.00
  • 100 ug
  • 10ug
  • 1 mg
  • 200 ug
  • 500 ug
  • 50ug
  • 5 mg
Description: Recombinant Mouse Growth Differentiation Factor 5 expressed in: E.coli

Epidermal Growth Factor (EGF), human recombinant

P1008-.5 500 µg
EUR 375.6
Description: Human epidermal growth factor (EGF) is a member of the EGF-family and plays an important role in the regulation of cell growth, proliferation, and differentiation through binding to its receptor EGFR.

Epidermal Growth Factor (EGF), human recombinant

P1008-5 5 mg
EUR 1646.4
Description: Human epidermal growth factor (EGF) is a member of the EGF-family and plays an important role in the regulation of cell growth, proliferation, and differentiation through binding to its receptor EGFR.

Wnt3a ELISA Kit| Mouse Protein Wnt-3a ELISA Kit

EF013348 96 Tests
EUR 826.8

Recombinant Human Protein Wnt-3a Protein, His, E.coli-100ug

QP8838-ec-100ug 100ug
EUR 489.6

Recombinant Human Protein Wnt-3a Protein, His, E.coli-10ug

QP8838-ec-10ug 10ug
EUR 240

Recombinant Human Protein Wnt-3a Protein, His, E.coli-1mg

QP8838-ec-1mg 1mg
EUR 1958.4

Recombinant Human Protein Wnt-3a Protein, His, E.coli-200ug

QP8838-ec-200ug 200ug
EUR 760.8

Recombinant Human Protein Wnt-3a Protein, His, E.coli-500ug

QP8838-ec-500ug 500ug
EUR 1272

Recombinant Human Protein Wnt-3a Protein, His, E.coli-50ug

QP8838-ec-50ug 50ug
EUR 315.6

5-Hydroxytryptamine Receptor 3A (5-HT3A) Antibody

20-abx013887
  • EUR 376.80
  • EUR 117.60
  • EUR 477.60
  • EUR 594.00
  • 100 ug
  • 10 ug
  • 200 ug
  • 300 µg

5-HT-3A Blocking Peptide

DF3502-BP 1mg
EUR 234

5-HT-3A Conjugated Antibody

C34152 100ul
EUR 476.4

Epidermal Growth Factor Receptor Peptide (985-996)

5-01114 4 x 1mg Ask for price

Insulin-like Growth Factor I (57-70)

5-01399 4 x 5mg Ask for price

Insulin-Like Growth Factor II (69-84)

5-01400 4 x 1mg Ask for price

Platelet-Derived Growth Factor Receptor Substrate 2

5-01775 4 x 1mg Ask for price

Prepro-Nerve Growth Factor (99-115) (mouse)

5-01801 4 x 1mg Ask for price

Epidermal Growth Factor Receptor Peptide (985-996)

A1021-5 5 mg
EUR 226.8
Description: EGFR (epidermal growth factor receptor) exists on the cell surface and is activated by the binding of its specific ligands, including epidermal growth factor and transforming growth factor ?. EGFR dimerization stimulates its intrinsic intracellular protein-tyrosine kinase activity.